Beta Blocker for Chronic Wound Healing

Phase 2 Terminated 40 enrolled University of California, Davis

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of treatment of chronic cutaneous ulcers and burn wounds with topical beta adrenergic antagonists (Timoptic®).

Timeline

Start: 2005-06
Primary completion: 2007-06
Completion: 2007-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Timolol	Other / unclassified	—	Topical

Beta Blocker for Chronic Wound Healing

Summary

Timeline

Drugs

Indications